Aegis Hospice, Inc. 2250 East Germann Road, Suite 1, Chandler, AZ, 85286 | |
(480) 219-4790 |
News Archive
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
To prepare healthcare providers for the strategic implications of reform and the tools needed for future success, the Premier healthcare alliance will host a series of Healthcare Reform Executive Briefings.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.
› Verified 7 days ago
Name | Aegis Hospice, Inc. |
---|---|
Location | 2250 East Germann Road, Suite 1, Chandler, Arizona |
Hospice ID | 031613 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 060 |
News Archive
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
To prepare healthcare providers for the strategic implications of reform and the tools needed for future success, the Premier healthcare alliance will host a series of Healthcare Reform Executive Briefings.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.
› Verified 7 days ago
NPI Number | 1356614754 |
Organization Name | Aegis Hospice, Inc |
Address | 2350 E Germann Rd Chandler, Arizona, 85286 |
Phone Number | (480)219-4790 |
News Archive
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
To prepare healthcare providers for the strategic implications of reform and the tools needed for future success, the Premier healthcare alliance will host a series of Healthcare Reform Executive Briefings.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.1 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.2 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 91.9 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 57.1 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 89.2 | 97.3 |
Patients who got timely treatment for shortness of breath | 84.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 86.7 | 93.3 |
News Archive
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
To prepare healthcare providers for the strategic implications of reform and the tools needed for future success, the Premier healthcare alliance will host a series of Healthcare Reform Executive Briefings.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.
› Verified 7 days ago
Home Health Aides | 2 |
Counselors | 1 |
Homemakers | 0.25 |
Medical Social Workers | 0.5 |
Physicians | 0.5 |
Registered Nurses | 2 |
Other Personnel | 3 |
Total Employees | 9.25 |
---|
News Archive
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
To prepare healthcare providers for the strategic implications of reform and the tools needed for future success, the Premier healthcare alliance will host a series of Healthcare Reform Executive Briefings.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.
In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.
› Verified 7 days ago
Brookdale Hospice Chandler Location: 2545 West Frye Road, Suite 10b, Chandler, Arizona, 85224 Phone: (480) 219-4790 |
East Valley Hospice, Plc Location: 1311 West Chandler Boulevard, Suite 200, Chandler, Arizona, 85224 Phone: (480) 219-4790 |
Emblem Hospice Location: 88 South San Marcos Place, Chandler, Arizona, 85225 Phone: (480) 219-4790 |
Aegis Hospice, Inc. Location: 2250 East Germann Road, Suite 1, Chandler, Arizona, 85286 Phone: (480) 219-4790 |